North American breast cancer therapeutics market is estimated to grow significantly at a CAGR of around 9.2% during the forecast period. The expenditure on breast cancer therapies and medicines is increasing very rapidly in the region which leads to the high rates of treatment of breast cancer. As per the American Cancer Society, breast cancer treatment can cost more than $100,000 in developed countries such as the US. However, the high cost of breast cancer drugs and surgeries across the developed countries are estimated to be the major constraints in the growth of the market.